Auxilium Pharma Stockholders Approve Proposed Merger With Endo - Quick Facts

(RTTNews) - Auxilium Pharmaceuticals Inc. (AUXL) announced Tuesday that it held a special meeting of its stockholders today at 8:30 a.m. ET to approve matters relating to the previously announced proposed merger with Endo International plc. (ENDP). The proposal to adopt the amended and restated agreement and plan of merger was passed by stockholders with about 84 percent of outstanding shares voting in favor.

Auxilium anticipates that the proposed merger transaction will close on Thursday, January 29, 2015.

In October, Endo International said that it entered into a definitive agreement to acquire all outstanding shares of Auxilium Pharmaceuticals for $33.25 per share in a cash and stock transaction, or a value of $2.6 billion, including repayment and assumption of debt.